跳至主要内容
临床试验/CTRI/2025/02/080644
CTRI/2025/02/080644尚未招募3 期

A Randomized controlled clinical study to evaluate the efficacy of Rasnadashamoola kwatha over Pathyadi kwatha in the management of Ardhavabhedhaka (Migraine)

DR SAMPREETA A S1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年2月25日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
symptoms of Ardhavabhedaka (Migraine)

研究概览

简要总结

Migraine is a common clinical problem characterized by unilateral throbbing, pulsating type of headache associated with vomiting, nausea, photophobia and Phonophobia. Which is very well correlated with Ardhavabhedaka explained in Ayurvedic classics.

Ardhavabhedaka is a clinical manifestation with dominancy of Vata and kapha dosha which produces cardinal symptoms like Ardhashirashula along with unilateral sever pain in Manya, Bhru, Shanka, Karna, Akshi and Lalata Pradesha. The pain episodes may be seen once in a month /15 days/10 days/suddenly at any time.

The incidence of migraine is at peak due to stressful life, Busy schedule and Altered Dietary habits. According to data from WHO, migraine is the third most prevalent medical condition. Prevalence of migraine usually starts after puberty and continues until middle and late ages of life. Frequency of occurrence is more common in females than males, in females 17% and in males 6% Yearly.

Here is an attempt to evaluate the efficacy of Rasnadashamula Kwata which is having properties like Vatakaphahara, Vedhanasthapana, Deepana, Pachana, and *Shirorujahara,*explained in Bhaishajya Ratnavali Vatavyadhi Chikitsa and its efficacy is compared with a control drug Pathyadi Kwata explained in Yogaratnakara Shiroroga Chikitsa.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1 Subjects aged between 16-60 years of either gender.
  • 2 Subjects fulfilling the Diagnostic criteria of Ardhavabhedaka (Migraine) 3 Subjects of Migraine without Aura.
  • 4 Both Fresh and treated cases will be considered for study.
  • 5 Subjects who are willing to sign the Consent.

排除标准

  • 1 Diagnosed cases of Anantavata (Trigeminal Neuralgia), Suryavartha, Dustapratishyaya (Chronic Sinusitis).
  • 2 Subjects having a history of severe head injury.
  • 3 Subjects with known systemic disorders [like- Uncontrolled hypertension, Cardiac problems] which interfere the intervention of Study.
  • 4 Known cases of psychological disorder.
  • 5 Subjects of Migraine with Aura 6 Any other illness which the researcher feels that interferes the intervention of study.

结局指标

主要结局

symptoms of Ardhavabhedaka (Migraine)

时间窗: 7day,15day,30day

Effect of Trial drug on improvement in classical

时间窗: 7day,15day,30day

次要结局

  • Safety of the trial drug and adverse drug reaction(and aggravation in the symptoms of Ardhavabhedaka)

研究者

发起方
DR SAMPREETA A S
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DR SAMPREETA A S

Sidramappa Danigond Memorial Trusts Ayurvedic Medical College Post Graduation Centre

研究点 (1)

Loading locations...

相似试验